| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enanta Pharmaceuticals Inc (ENTA) has 8 insiders with recent SEC Form 4 filings, including 5 buys and 11 sells. ENTA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.0K | $13.16M | - | |
| Other | 371.4K | $5.70M | - | |
| Other | 38.3K | $588.0K | - | |
| Other | 30.6K | $469.7K | - | |
| Other | 21.8K | $334.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2015 | Or Yat Sun59 | Chief Scientific Officer | Sell | 3,750 | $42.47 | $159,264.75 | -1.7% | |
| Jun 11, 2015 | Mellett Paul J63 | Treasurer And CFO | Sell | 7,500 | $42.51 | $318,812.25 | -7.7% | |
| Jun 5, 2015 | Or Yat Sun59 | Chief Scientific Officer | Sell | 10,750 | $42.02 | $451,662.32 | -4.7% | |
| May 19, 2015 | Mellett Paul J63 | Treasurer And CFO | Sell | 24,000 | $40.13 | $963,093.60 | -19.7% | |
| May 11, 2015 | Or Yat Sun59 | Chief Scientific Officer | Sell | 8,000 | $36.13 | $289,044.80 | -3.4% | |
| Mar 9, 2015 | Luly Jay R.71 | President And CEO | Sell | 15,000 | $33.37 | $500,520.67 | -1.0% | |
| Feb 20, 2015 | Luly Jay R.71 | President And CEO | Sell | 15,000 | $35.35 | $530,289.00 | -3.0% | |
| Feb 19, 2015 | Buckley Stephen Jr. | Director | Buy | 1,000 | $34.00 | $33,996.00 | +41.7% | |
| Feb 17, 2015 | Gardiner Nathaniel S. | Sr. VP &General Counsel | Buy | 1,400 | $33.23 | $46,522.00 | +100.0% | |
| Jan 16, 2015 | Mellett Paul J63 | Treasurer And CFO | Sell | 4,500 | $49.45 | $222,505.06 | -1.8% |